LiveActive security incident?Get immediate response
CVE Record

CVE-2021-23236: Fresenius Kabi Agilia Connect Infusion System uncontrolled resource consumption

Requests may be used to interrupt the normal operation of the device. When exploited, Fresenius Kabi Agilia Link+ version 3.0 must be rebooted via a hard reset triggered by pressing a button on the rack system.

HighCVSS 7.5Not KEV-listedUpdated
Glexia's TakeAutomated analysishigh

Security readout for executives and security teams

Plain-English summary

This vulnerability can let network requests disrupt Fresenius Kabi Agilia Link+ operation. The cited description says affected version 3.0 may require a physical hard reset on the rack system, creating clinical availability risk rather than data theft risk.

Executive priority

Treat as high priority where Agilia Link+ is in clinical use, because the primary impact is service availability of infusion infrastructure. Prioritize inventory, network exposure reduction, and vendor-guided remediation.

Technical view

CVE-2021-23236 is CWE-400 uncontrolled resource consumption in Fresenius Kabi Agilia Link+. CVSS 3.1 is 7.5, with network attack vector, low complexity, no privileges, no user interaction, and high availability impact. The sources do not show confidentiality or integrity impact.

Likely exposure

Most relevant exposure is healthcare environments running Fresenius Kabi Agilia Link+, specifically version 3.0 per the CVE description. The affected version range is otherwise incomplete in the provided bundle, so inventory confirmation is necessary.

Exploitation context

The source bundle does not cite active exploitation, and KEV is false. The risk is unauthenticated network-triggered denial of normal device operation, with recovery described as a hard reset using a physical rack button.

Researcher notes

Evidence supports a network-accessible availability flaw requiring no authentication. The bundle does not provide exploit details, patch status, fixed versions, or complete affected-version boundaries. Avoid assuming broader Agilia product impact without vendor confirmation.

Mitigation direction

  • Check Fresenius Kabi and CISA guidance for supported remediation.
  • Identify all Agilia Link+ systems and record firmware/software versions.
  • Restrict network reachability to trusted clinical and management networks.
  • Avoid exposing device interfaces to untrusted or general-purpose networks.
  • Prepare operational procedures for safe recovery and hard resets.
  • Coordinate changes with clinical engineering before altering device connectivity.

Validation and detection

  • Confirm whether Agilia Link+ version 3.0 is deployed.
  • Map network paths that can reach affected rack systems.
  • Review logs or incident records for unexpected device interruptions.
  • Verify segmentation limits access to authorized systems only.
  • Track vendor or CISA updates for clarified affected versions.
  • Document compensating controls and clinical recovery ownership.
Prepared
Confidence
medium
Sources
3

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cwe · low confidence lookup

CWE-400: Exact CWE lookup

Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.

Open ATT&CK lookup
cve · low confidence lookup

CVE-2021-23236 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
High
CVSS
7.5 (3.1)
Known Exploited
No
Published

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

1CVSS vectors
0Timeline events
0ADP providers
2Source links

CVSS vector scores

1 official score

We collect every scored CVSS vector available in the official CNA and ADP containers. When more than one version is present, the table keeps the source vectors side by side instead of collapsing them into the highest score.

ScoreVersionSeverityVectorExploitImpactSource
7.5CVSS 3.1HighCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H3.93.6Primary CVE score

Vulnerability scoring details

Base CVSS 3.1 score

7.5High
CVSS 3.1 vector shape for CVE-2021-23236Attack VectorAttack ComplexityPrivileges RequiredUser InteractionScopeConfidentiality ImpactIntegrity ImpactAvailability Impact

Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Attack Vector
NetworkAdjacentLocalPhysical
Attack Complexity
LowHigh
Privileges Required
NoneLowHigh
User Interaction
NoneRequired
Scope
ChangedUnchanged
Confidentiality Impact
HighLowNone
Integrity Impact
HighLowNone
Availability Impact
HighLowNone

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
Fresenius KabiAgilia Link+unspecifiedListed
Weakness

CWE details

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.

CWE-400 · source CWE mapping

Uncontrolled Resource Consumption

Uncontrolled Resource Consumption represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.